scPharmaceuticals Inc.

scPharmaceuticals Inc. is a biotechnology company whose drug development pipeline relies on animal testing to meet regulatory requirements for safety and efficacy. The company’s lead product, a subcutaneous drug delivery system, required preclinical testing on animals as part of its FDA approval process. This reliance on animal models is standard in the pharmaceutical industry but triggers exclusion under the animal exploitation category.

Cruelty Free Investors, a screening organization focused on animal welfare in investment portfolios, flags scPharmaceuticals for its involvement in animal testing. While specific details on the number or species of animals used are not publicly disclosed in routine SEC filings, the company’s status as a clinical-stage biopharmaceutical entity implies ongoing animal research is integral to its business model. There is no public commitment from scPharmaceuticals to adopt or invest in non-animal testing alternatives.